Rho激酶的生理及病理生理研究进展

被引：10

作者：

李琴

李晓宇

刘皋林

机构：

[1] 上海交通大学附属第一人民医院临床药学研究室

来源：

中国药学杂志 | 2011年 / 46卷 / 24期

关键词：

Rho激酶; 生理; 病理生理; 研究进展;

D O I：

暂无

中图分类号：

R363 [病理生理学];

学科分类号：

100104 ;

摘要：

目的分析并归纳Rho激酶的生理及病理生理作用研究进展。方法查阅近年有关Rho激酶的国内外文献,基于目前和Rho激酶相关的一些分子、细胞、动物的实验研究及临床试验,对Rho激酶的生理及病理生理作用进行分析、归纳和综合。结果与结论 Rho激酶已经成为很有价值的药物作用靶点,Rho激酶抑制剂的不断研发为许多心脑血管及肿瘤等疾病的治疗提供了新的希望。

引用

页码：1860 / 1864

页数：5

共 15 条

[1] Neuroprotective Potential of Fasudil Mesylate in Brain Ischemia-Reperfusion Injury of Rats [J].

Li, Qin ;

Huang, Xian-Ju ;

He, Wei ;

Ding, Jie ;

Jia, Jun-Ting ;

Fu, Gang ;

Wang, Hong-Xing ;

Guo, Lian-Jun .

CELLULAR AND MOLECULAR NEUROBIOLOGY, 2009, 29 (02) :169-180

[2]

Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction[J] . Kazuo Yano,Koh Kawasaki,Tsuyoshi Hattori,Shunsuke Tawara,Yoshinori Toshima,Ichiro Ikegaki,Yasuo Sasaki,Shin-ichi Satoh,Toshio Asano,Minoru Seto.European Journal of Pharmacology . 2008 (1)

[3]

Fasudil, a Rho kinase （ROCK） inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons[J] . Kentaro Yamashita,Yoshinori Kotani,Yoshimi Nakajima,Masamitsu Shimazawa,Shin-ichi Yoshimura,Shigeru Nakashima,Toru Iwama,Hideaki Hara.Brain Research . 2007

[4] Rho kinases in cardiovascular physiology and pathophysiology [J].

Loirand, G ;

Guérin, P ;

Pacaud, P .

CIRCULATION RESEARCH, 2006, 98 (03) :322-334

[5] Inhibition of rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection [J].

Rikitake, Y ;

Kim, HH ;

Huang, ZH ;

Seto, M ;

Yano, K ;

Asano, T ;

Moskowitz, MA ;

Liao, JK .

STROKE, 2005, 36 (10) :2251-2257

[6]

Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo[J] . Toyotaka Yada,Hiroaki Shimokawa,Osamu Hiramatsu,Tatsuya Kajita,Fumiyuki Shigeto,Etsuro Tanaka,Yoshiro Shinozaki,Hidezo Mori,Takahiko Kiyooka,Masashi Katsura,Seitaro Ohkuma,Masami Goto,Yasuo Ogasawara,Fumihiko Kajiya.Journal of the American College of Cardiology . 2005 (4)

[7] Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure [J].

Kishi, T ;

Hirooka, Y ;

Masumoto, A ;

Ito, K ;

Kimura, Y ;

Inokuchi, K ;

Tagawa, T ;

Shimokawa, H ;

Takeshita, A ;

Sunagawa, K .

CIRCULATION, 2005, 111 (21) :2741-2747

[8] Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells [J].

Hiroki, J ;

Shimokawa, H ;

Higashi, M ;

Morikawa, K ;

Kandabashi, T ;

Kawamura, N ;

Kubota, T ;

Ichiki, T ;

Amano, M ;

Kaibuchi, K ;

Takeshita, A .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (02) :537-546

[9]

Partial protective effect of Y-27632, a Rho kinase inhibitor, against hepatic ischemia–reperfusion injury in rats[J] . Atsuhiro Kawaguchi,Masami Ohmori,Akio Fujimura.European Journal of Pharmacology . 2004 (1)

[10] Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm [J].

Mohri, M ;

Shimokawa, H ;

Hirakawa, Y ;

Masumoto, A ;

Takeshita, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :15-19

← 1 2 →